News
CVSI
0.011
+4.76%
0.001
CV Sciences Resolves Legal Dispute, Refocuses on Operations
TipRanks · 6h ago
Weekly Report: what happened at CVSI last week (1019-1023)?
Weekly Report · 17h ago
Weekly Report: what happened at CVSI last week (1012-1016)?
Weekly Report · 10/19 10:10
Weekly Report: what happened at CVSI last week (1005-1009)?
Weekly Report · 10/12 10:15
Weekly Report: what happened at CVSI last week (0928-1002)?
Weekly Report · 10/05 10:14
DEA judge pauses marijuana rescheduling hearing
TipRanks · 09/30 14:10
Weekly Report: what happened at CVSI last week (0921-0925)?
Weekly Report · 09/28 10:10
Weekly Report: what happened at CVSI last week (0914-0918)?
Weekly Report · 09/21 10:10
Weekly Report: what happened at CVSI last week (0907-0911)?
Weekly Report · 09/14 10:14
CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework
Barchart · 09/08 16:00
Weekly Report: what happened at CVSI last week (0831-0904)?
Weekly Report · 09/07 10:08
Weekly Report: what happened at CVSI last week (0824-0828)?
Weekly Report · 08/31 10:15
Weekly Report: what happened at CVSI last week (0817-0821)?
Weekly Report · 08/24 10:16
Weekly Report: what happened at CVSI last week (0810-0814)?
Weekly Report · 08/17 10:17
CV Sciences Reports Q2 Results Amid Regulatory Reprieve
TipRanks · 08/13 21:11
CV Sciences Q2 2026 Earnings Call Transcript
Benzinga · 08/13 21:01
CV Sciences Non-GAAP EPS of $0.00, revenue of $2.99M
Seeking Alpha · 08/13 20:01
CV Sciences Q2 Adj. EPS $0.00, Sales $2.985M Down From $3.620M YoY
Benzinga · 08/13 20:01
Here are the major earnings after the close Thursday
Seeking Alpha · 08/13 16:47
CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results
Barchart · 08/13 15:00
More
Webull provides a variety of real-time CVSI stock news. You can receive the latest news about Cv Sciences through multiple platforms. This information may help you make smarter investment decisions.
About CVSI
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.